EcoR1 Capital as of March 31, 2023
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 58 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Prothena Corp SHS (PRTA) | 18.1 | $562M | 12M | 48.47 | |
| Sarepta Therapeutics (SRPT) | 13.3 | $413M | 3.0M | 137.83 | |
| Apellis Pharmaceuticals (APLS) | 11.6 | $360M | 5.5M | 65.96 | |
| Galapagos Nv Spon Adr (GLPG) | 5.3 | $164M | 4.2M | 38.64 | |
| Anaptysbio Inc Common (ANAB) | 5.3 | $164M | 7.5M | 21.76 | |
| Xencor (XNCR) | 4.7 | $147M | 5.3M | 27.89 | |
| Morphic Hldg (MORF) | 4.7 | $145M | 3.8M | 37.64 | |
| Revolution Medicines (RVMD) | 3.7 | $116M | 5.4M | 21.66 | |
| ACADIA Pharmaceuticals (ACAD) | 3.6 | $113M | 6.0M | 18.82 | |
| Arvinas Ord (ARVN) | 3.3 | $102M | 3.7M | 27.32 | |
| Zymeworks Del (ZYME) | 2.9 | $91M | 10M | 9.04 | |
| Springworks Therapeutics (SWTX) | 2.9 | $89M | 3.5M | 25.74 | |
| Kura Oncology (KURA) | 2.6 | $81M | 6.6M | 12.23 | |
| Relay Therapeutics (RLAY) | 2.2 | $69M | 4.2M | 16.47 | |
| Janux Therapeutics (JANX) | 1.5 | $46M | 3.8M | 12.10 | |
| Voyager Therapeutics (VYGR) | 1.0 | $30M | 3.9M | 7.71 | |
| Dyne Therapeutics (DYN) | 0.9 | $27M | 2.3M | 11.52 | |
| Ngm Biopharmaceuticals (NGM) | 0.8 | $26M | 6.4M | 4.08 | |
| Alector (ALEC) | 0.8 | $25M | 4.1M | 6.19 | |
| Kymera Therapeutics (KYMR) | 0.8 | $24M | 796k | 29.63 | |
| Edgewise Therapeutics (EWTX) | 0.8 | $23M | 3.5M | 6.67 | |
| Nuvation Bio Com Cl A (NUVB) | 0.7 | $23M | 14M | 1.66 | |
| Allogene Therapeutics (ALLO) | 0.7 | $22M | 4.5M | 4.94 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.7 | $22M | 5.6M | 3.85 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.7 | $21M | 1.3M | 16.06 | |
| Graphite Bio | 0.7 | $21M | 8.5M | 2.45 | |
| Atea Pharmaceuticals (AVIR) | 0.7 | $21M | 6.2M | 3.35 | |
| Adicet Bio (ACET) | 0.7 | $21M | 3.6M | 5.76 | |
| Oric Pharmaceuticals (ORIC) | 0.6 | $20M | 3.4M | 5.70 | |
| Tango Therapeutics (TNGX) | 0.5 | $17M | 4.2M | 3.95 | |
| Ovid Therapeutics (OVID) | 0.5 | $16M | 6.1M | 2.58 | |
| Chinook Therapeutics | 0.3 | $10M | 446k | 23.15 | |
| Generation Bio (GBIO) | 0.3 | $8.4M | 2.0M | 4.30 | |
| Poseida Therapeutics I (PSTX) | 0.3 | $8.2M | 2.7M | 3.08 | |
| Third Harmonic Bio (THRD) | 0.2 | $7.4M | 1.8M | 4.12 | |
| Prime Medicine (PRME) | 0.2 | $7.4M | 600k | 12.30 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.2 | $6.2M | 2.9M | 2.13 | |
| Beam Therapeutics (BEAM) | 0.2 | $6.1M | 199k | 30.62 | |
| Arcutis Biotherapeutics (ARQT) | 0.1 | $4.6M | 415k | 11.00 | |
| Macrogenics (MGNX) | 0.1 | $4.4M | 619k | 7.17 | |
| Aligos Therapeutics (ALGS) | 0.1 | $3.5M | 3.9M | 0.87 | |
| Cullinan Oncology (CGEM) | 0.1 | $2.5M | 246k | 10.23 | |
| Tempest Therapeutics (TPST) | 0.1 | $2.4M | 1.0M | 2.32 | |
| Black Diamond Therapeutics (BDTX) | 0.1 | $2.3M | 1.2M | 1.89 | |
| Surface Oncology | 0.1 | $2.2M | 3.1M | 0.70 | |
| Erasca (ERAS) | 0.1 | $2.0M | 678k | 3.01 | |
| Eucrates Biomedical Acqu Cor SHS | 0.1 | $2.0M | 200k | 10.14 | |
| Hookipa Pharma Inc equity (HOOK) | 0.1 | $1.8M | 2.5M | 0.74 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.1 | $1.6M | 963k | 1.66 | |
| Gracell Biotechnologies Sponsored Ads | 0.0 | $1.5M | 799k | 1.86 | |
| Newamsterdam Pharma Company *w Exp 11/22/202 (NAMSW) | 0.0 | $884k | 67k | 13.26 | |
| Eucrates Biomedical Acqu Cor *w Exp 10/23/202 | 0.0 | $676k | 67k | 10.14 | |
| Kronos Bio (KRON) | 0.0 | $477k | 327k | 1.46 | |
| Selecta Biosciences (RNAC) | 0.0 | $278k | 200k | 1.39 | |
| Caremax *w Exp 06/08/202 (CMAXW) | 0.0 | $267k | 100k | 2.67 | |
| Cyteir Therapeutics | 0.0 | $80k | 44k | 1.82 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $40k | 67k | 0.60 | |
| Iteos Therapeutics (ITOS) | 0.0 | $18k | 1.3k | 13.61 |
